Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Pediatr Nephrol. 2014 Dec 5;30(4):665–676. doi: 10.1007/s00467-014-2987-0

Figure 3. Comparison of peak biomarker concentrations across 4 AKI categories: No AKI, SCr-AKI only, CysC-AKI only, both SCr + CysC AKI.

Figure 3

For all 4 studied biomarkers, biomarker concentrations are compared between 4 groups: patients with no AKI by SCr or CysC rise; patients who only have acute kidney injury by SCr rise; patients who only have acute kidney injury by CysC rise; patients who have acute kidney injury using both methods. The p-values within the graphs are from performance of a non-parametric test for trend across groups.

NGAL: neutrophil gelatinase-associated lipocalin; AKI: acute kidney injury; SCR-AKI: acute kidney injury defined by rise in serum creatinine from baseline; CysC-AKI: acute kidney injury defined by rise in serum cystatin C from baseline; SCr+CysC-AKI: acute kidney injury defined by rise in serum creatinine and Cystatin C from baseline; IL-18: interleukin-18; KIM-1: kidney injury molecule-1; CysC: cystatin C.